Ironwood Pharmaceuticals | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Almirall EUR 2.32B 14.19M 2024-06
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amarin USD 750.62M 49.24M 2024-09
Ardelyx USD 435.75M 67.89M 2024-12
Astellas Pharma JPY 3.45T 10.61B 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Exact Sciences USD 5.93B 820.43M 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Incyte USD 5.44B 431.89M 2024-12
Ironwood Pharmaceuticals USD 351.3M 38.22M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Moderna USD 14.14B 1.66B 2024-12
Myriad Genetics USD 1.03B 53.7M 2024-12
Pacira USD 1.55B 31.82M 2024-12
PTC Therapeutics USD 1.71B 137.21M 2024-12
Sarepta Therapeutics USD 3.96B 363.24M 2024-12
Takeda JPY 15.11T 533.85B 2024-12
Ultragenyx Pharmaceutical USD 1.5B 34.91M 2024-12



Ironwood Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.